|
|
Post by peppy on Dec 8, 2017 22:42:13 GMT -5
MNKD Weekly chart. "The consolidation."
|
|
|
|
Post by peppy on Dec 8, 2017 23:13:34 GMT -5
the thought is floating through, if and when the 140 million shares are authorized, survival is assured, the share price will go up?
SCRIPTS and enough money for the scheduled trials.
INSURANCE coverage.
I think this is a consolidation.
We know we have the best insulin there is,
THOUGHTS? what are you thinking? With all the pain it is kind of amazing, mike C (and board) are building this. Nate's $27 number.... the longs jump on, the short squeeze takes it up? the long fabled short squeezey? Thoughts? Tell me.
|
|
|
|
Post by buyitonsale on Dec 9, 2017 1:00:02 GMT -5
Wednesday đ
|
|
|
|
Post by peppy on Dec 9, 2017 1:06:57 GMT -5
Monthly, the month hasn't closed. last month an inside month. the 20 month moving average. Price hasn't been above that in 27 months. the 50 month moving average the target. When reading a price wedge.
To my eye ball the yellow line represents a price neckline of sorts. break and hold of $3.73. $5.00 then $8.00 the may 2012 low the next hard resistance. 4.35 - .66 = 3.69 3.73 + 3.69 = 7.42. the measured move. alrighty then. I looked.
all comments and observations welcomed.
|
|
|
|
Post by mytakeonit on Dec 9, 2017 3:39:56 GMT -5
Peppy - I still don't know what the heck you are saying ... even though I'm drinking a lot of wine. All I know is that $27 is higher than all those lines.
Just wait till I return from Vegas.
|
|
|
|
Post by cretin11 on Dec 9, 2017 12:29:11 GMT -5
peppy, to answer your question, I donât think the 140 mil share auth vote will cause share price to go way up as you posit. I suspect everyone knows the shares will be authorized, so it wonât be âbig newsâ when the positive vote is announced. My concern is about how many shares will actually be issued, and how much that dilution will hurt share price. Hopefully that too is somewhat baked into current share price and we donât get hurt too badly. We need scripts to move up faster, and for some deal(s) to get done.
|
|
|
|
Post by akemp3000 on Dec 9, 2017 15:25:02 GMT -5
You asked for thoughts. My guess is the request to authorize shares is twofold. One is to use a small amount of the shares to do a joint marketing deal with a large BP either domestically or internationally. The balance would remain on the shelf for future opportunities in the next two or three years just as Mike stated. If say 28 million (20%) of the 140 million were sold at $6 per share, this would generate $168M to help fund the new marketing partnership. While there would be a dilution component, the upside of the new partnership would outweigh the dilution and the pps would rise. Imagine the credibility and press at this important moment in time if it were announced that someone like Merck has recognized that Afrezza is the "real deal" and has decided to buy-in and team up with Mannkind to market and sell Afrezza. This would especially be big news following the failed Sanofi deal.
Some may question why any BP would pay $6 when the current market price is $3. Recent history just proved this can happen. This is the beauty of having the new shares to use in negotiations for a serious buy-in. If this announcement were to occur following the vote, then Michael Kovacocy might just be spot on suggesting $10 by the end of the year. All of this is of course just a swag guess. As to thoughts regarding the charts, I love following them and sincerely appreciate the great effort it takes to create them but as an investor as opposed to a trader, my hope is that a one sentence announcement relegates all prior charts to history. This is what I'd like to see. GLTA
|
|
|
|
Post by sellhighdrinklow on Dec 9, 2017 15:44:38 GMT -5
You asked for thoughts. My guess is the request to authorize shares is twofold. One is to use a small amount of the shares to do a joint marketing deal with a large BP either domestically or internationally. The balance would remain on the shelf for future opportunities in the next two or three years just as Mike stated. If say 28 million (20%) of the 140 million were sold at $6 per share, this would generate $168M to help fund the new marketing partnership. While there would be a dilution component, the upside of the new partnership would outweigh the dilution and the pps would rise. Imagine the credibility and press at this important moment in time if it were announced that someone like Merck has recognized that Afrezza is the "real deal" and has decided to buy-in and team up with Mannkind to market and sell Afrezza. This would especially be big news following the failed Sanofi deal. Some may question why any BP would pay $6 when the current market price is $3. Recent history just proved this can happen. This is the beauty of having the new shares to use in negotiations for a serious buy-in. If this announcement were to occur following the vote, then Michael Kovacocy might just be spot on suggesting $10 by the end of the year. All of this is of course just a swag guess. As to thoughts regarding the charts, I love following them and sincerely appreciate the great effort it takes to create them but as an investor as opposed to a trader, my hope is that a one sentence announcement relegates all prior charts to history. This is what I'd like to see. GLTA Imho, the next money raise will be post STAT study release and the shares will be sold north of $10. |
|
|
|
Post by akemp3000 on Dec 9, 2017 16:36:40 GMT -5
Imho, the next money raise will be post STAT study release and the shares will be sold north of $10. That would be great. Maybe Mannkind is already using STAT study feedback in some backroom negotiations prior to their release. |
|
|
|
Post by dreamboatcruise on Dec 9, 2017 20:29:58 GMT -5
You asked for thoughts. My guess is the request to authorize shares is twofold. One is to use a small amount of the shares to do a joint marketing deal with a large BP either domestically or internationally. The balance would remain on the shelf for future opportunities in the next two or three years just as Mike stated. If say 28 million (20%) of the 140 million were sold at $6 per share, this would generate $168M to help fund the new marketing partnership. While there would be a dilution component, the upside of the new partnership would outweigh the dilution and the pps would rise. Imagine the credibility and press at this important moment in time if it were announced that someone like Merck has recognized that Afrezza is the "real deal" and has decided to buy-in and team up with Mannkind to market and sell Afrezza. This would especially be big news following the failed Sanofi deal. Some may question why any BP would pay $6 when the current market price is $3. Recent history just proved this can happen. This is the beauty of having the new shares to use in negotiations for a serious buy-in. If this announcement were to occur following the vote, then Michael Kovacocy might just be spot on suggesting $10 by the end of the year. All of this is of course just a swag guess. As to thoughts regarding the charts, I love following them and sincerely appreciate the great effort it takes to create them but as an investor as opposed to a trader, my hope is that a one sentence announcement relegates all prior charts to history. This is what I'd like to see. GLTA What percent likelihood do you attach to your guesses? All I can say is there is 100% likelihood that management is requesting the right to dilute by 140M without seeking further approval. I realize that if I made any further prognostication it would be pure speculation or trying to convince either myself or someone else of a story I'm making up. Just my perspective  |
|
|
|
Post by akemp3000 on Dec 10, 2017 0:14:16 GMT -5
You asked for thoughts. My guess is the request to authorize shares is twofold. One is to use a small amount of the shares to do a joint marketing deal with a large BP either domestically or internationally. The balance would remain on the shelf for future opportunities in the next two or three years just as Mike stated. If say 28 million (20%) of the 140 million were sold at $6 per share, this would generate $168M to help fund the new marketing partnership. While there would be a dilution component, the upside of the new partnership would outweigh the dilution and the pps would rise. Imagine the credibility and press at this important moment in time if it were announced that someone like Merck has recognized that Afrezza is the "real deal" and has decided to buy-in and team up with Mannkind to market and sell Afrezza. This would especially be big news following the failed Sanofi deal. Some may question why any BP would pay $6 when the current market price is $3. Recent history just proved this can happen. This is the beauty of having the new shares to use in negotiations for a serious buy-in. If this announcement were to occur following the vote, then Michael Kovacocy might just be spot on suggesting $10 by the end of the year. All of this is of course just a swag guess. As to thoughts regarding the charts, I love following them and sincerely appreciate the great effort it takes to create them but as an investor as opposed to a trader, my hope is that a one sentence announcement relegates all prior charts to history. This is what I'd like to see. GLTA What percent likelihood do you attach to your guesses? All I can say is there is 100% likelihood that management is requesting the right to dilute by 140M without seeking further approval. I realize that if I made any further prognostication it would be pure speculation or trying to convince either myself or someone else of a story I'm making up. Just my perspective You can't be serious. I'm guessing a likelihood of 30% attached to my guess. It is absolutely absurd to think there's a 100% likelihood that management is requesting the right to dilute by 140M without seeking further approval. I do respect your opinion to guess like all the rest us and enjoy reading your perspective. I also take joy in knowing that you're going to be so wrong |
|
|
|
Post by careful2invest on Dec 10, 2017 2:09:14 GMT -5
What percent likelihood do you attach to your guesses? All I can say is there is 100% likelihood that management is requesting the right to dilute by 140M without seeking further approval. I realize that if I made any further prognostication it would be pure speculation or trying to convince either myself or someone else of a story I'm making up. Just my perspective You can't be serious. I'm guessing a likelihood of 30% attached to my guess. It is absolutely absurd to think there's a 100% likelihood that management is requesting the right to dilute by 140M without seeking further approval. I do respect your opinion to guess like all the rest us and enjoy reading your perspective. I also take joy in knowing that you're going to be so wrong Yes, everyone is entitled to their opinion. And I agree with Akemp, dbc is "going to be so wrong" There is no doubt in my mind that Mike C is savy enough to know the effect of how adding 140 million shares to the float would devastate the pps if he did not follow it up quickly with an announcement of a very promising deal. In addition, combine his stellar business decisions thus far with his recent comments in the Motley Fool article including all of the attributes of where MNKD is currently with Afrezza and when he added that he wishes that he was able to buy more shares. Good thing is...I am still able to buy more shares, and that is exactly what I plan to do this week. GLTA! |
|
|
|
Post by dreamboatcruise on Dec 10, 2017 11:30:13 GMT -5
akemp3000 ... what I state is what the proxy vote is. That is why I say 100%... because it (requesting the vote) has already been done. Read the proxy if you haven't. You can imagine/hope that they don't use the right to dilute by close to the 140M they will have shareholder authorization to, but it is the right to do so they are requesting. I do find it interesting that you stated it to be your guess of what would happen and now state that as 30% likely... i.e. you seem to be stating/betting on something you think with 70% probability will not come to pass.
|
|
|
|
Post by akemp3000 on Dec 10, 2017 12:02:52 GMT -5
akemp3000 ... what I state is what the proxy vote is. That is why I say 100%... because it (requesting the vote) has already been done. Read the proxy if you haven't. You can imagine/hope that they don't use the right to dilute by close to the 140M they will have shareholder authorization to, but it is the right to do so they are requesting. I do find it interesting that you stated it to be your guess of what would happen and now state that as 30% likely... i.e. you seem to be stating/betting on something you think with 70% probability will not come to pass. Haha priceless...I was simply responding to a request that I assign probability to a swag guess. I suggested 30% for a selling of 20% of the shares. I'll suggest 73% for a selling of at least 8% of shares. I'll suggest 14% that 52% or more will be sold in the near future. I'll suggest 42% for a selling of 15% of shares. I'll suggest 85% that at least 75% shares will be shelved for future use.... Hope this helps |
|
|
|
Post by dreamboatcruise on Dec 10, 2017 12:30:37 GMT -5
akemp3000... It would help me visualize if you generated a cumulative distribution function curve Would also be interesting to know a few years ago (assuming you were following MNKD then) what probability you would have attached to MNKD eventually using up all of their then authorized shares, as they now basically have. That would help me predict a probability for the accuracy of your predictions
|
|
